Inovio Pharmaceuticals, Inc.
INO
$2.02
$0.105.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -93.44% | -19.42% | -1.61% | 22.98% | 21.94% |
| Total Depreciation and Amortization | 1.08% | -0.24% | -4.16% | 1.29% | -7.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,176.92% | 159.45% | -862.94% | -77.43% | -112.96% |
| Change in Net Operating Assets | -873.73% | 101.98% | -553.08% | 74.44% | -260.94% |
| Cash from Operations | -3.66% | 22.56% | -36.67% | 28.35% | 2.72% |
| Capital Expenditure | -120.06% | 47.98% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.18% | 69,807.89% | -99.98% | 145.67% | 35.12% |
| Cash from Investing | 67.87% | 10,297.10% | -100.15% | 146.09% | 41.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -91.58% | 1,860.97% | -96.11% |
| Repurchase of Common Stock | 94.83% | 53.10% | -- | 100.00% | 97.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 71,715.80% | -103.39% | -96.47% | 4,311.96% | -98.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 178.49% | 39.90% | -158.69% | 447.31% | -185.90% |